Edwin Mansfield was a research pioneer into the economics of R and D and technological change. As appreciation and remembrance for his scholarly contributions, eminent scholars have contributed original papers for this edited volume. The authors have followed the 'Mansfieldian' approach of...

The worst chemical disaster ever could be happening right now. In India and Bangladesh between forty and eighty million people are at risk of consuming too much arsenic from well water that might have already caused one hundred thousand cancer cases and thousands of deaths. Many millions...

A crucial issue in the era of globalisation and internationalization, is whether the relationship between investment and finance is beneficial to growth and development. Received wisdom is that Research and Development is essential not only for maintaining productivity, but also for competing in...

The book investigates the interplay of brand equity and technological assets at the corporate level. In a grounded theory approach it develops a model of how companies in technology intensive industries can improve the appropriation of the returns of their intangible technological assets with...

Fehlschlagende Projekte - insbesondere im Umfeld von Forschung und Entwicklung - werden häufig erst wesentlich später abgebrochen, als eine rationale, ökonomische Betrachtung empfehlen würde. Durch solche verspäteten Abbrüche entstehen Unternehmen jedoch hohe Effizienz- und...

Endogene Sunk Costs und die Kostenstruktur -- Endogene Sunk Costs in einem „Love of Variety“ Modell -- Endogene Sunk Costs in einem „Ideal Variety“ Modell -- Anwendungen der Modelle mit endogenen Sunk Costs -- Schlussbemerkungen.

Deals with the topic of out-licensing as a novel form of risk-sharing collaborations. The phenomenon of out-licensing is illustrated by three major case studies of Novartis, Schering and Roche as well as several smaller case studies. This book applies the Nobel Prize awarded economic theory of...

Traditionally resources for R and D projects are allocated via planning and budgeting procedures, evaluation methods and hierarchical decision-committees. This book presents resource allocation via internal markets as an alternative to such hierarchical decision procedures. Internal R and D...

This book proposes an integrated approach to patent risk and capital budgeting in pharmaceutical research and development (R and D), developing an option-based view (OBV) of imperfect patent protection, which draws upon contingent-claims analysis, stochastic game theory, as well as novel...